ZLD FA summary, page-4

The two companies have totally different business 'products' despite having some of the same people / directors.

Auscann is all about growing medical cannibis. They have agreement with a Canadian supplier and a Chilean supplier. The model is simple and uncomplicated.

Zelda is doing trials using marijuana to tackle so many diseases and ailments. It is cutting edge, very complicated model using worlds best scientists.
Trials next year insomnia, dermatitis. Also breast cancer, brain cancer etc

We are on a big winner here and not such a long wait for sp rise movement. Considerable research data on people has been collected and analysed by the California not for profit organisation Aunt Zelda. All the data is now ours along with Mara Gordon who has been described as an absolute superstar. Mara analysis's data using computer programs, and is a major shareholder of Zelda. There are also amazing scientists from Spain. Spain is a major player in medical marijuana research. Our company has the best minds and the best human research data.

My understanding is the Intension is to get to Type II trial, as quickly and low costly, then on-sell the trial results to major pharmaceutical companies for further more costly bigger sample human trials. Those pharmaceutical company can pay $100 million for the successful Type II trial results. Zelda would also get a revenue stream the product ever gets to becoming a passed consumer product.

This is a massive buy opportunity.
Right now there are a changing of old mining shareholders from the old shell company / ex-mining company known as Gleneagle Gold, to those bio-medical type shareholders. ie There is a changing of shareholder profile. That will take a few weeks.